-
Je něco špatně v tomto záznamu ?
The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
M. Steffl, J. Sima, K. Shiells, I. Holmerova,
Jazyk angličtina Země Nový Zéland
Typ dokumentu časopisecké články
Grantová podpora
NV15-32942A
MZ0
CEP - Centrální evidence projektů
NV16-29182A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Plný text - Článek
Zdroj
NLK
Directory of Open Access Journals
od 2006
Free Medical Journals
od 2006
PubMed Central
od 2006
Europe PubMed Central
od 2006
ProQuest Central
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Open Access Digital Library
od 2006-01-01
Taylor & Francis Open Access
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2006-01-01
Public Health Database (ProQuest)
od 2006-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
29225462
DOI
10.2147/cia.s150826
Knihovny.cz E-zdroje
- MeSH
- lidé MeSH
- odds ratio MeSH
- osobní újma zaviněná nemocí MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- svalová slabost ekonomika epidemiologie MeSH
- výdaje na zdravotnictví statistika a číselné údaje MeSH
- zdravotnické přehledy MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
- Evropa MeSH
Muscle weakness and associated diseases are likely to place a considerable economic burden on government health care expenditure. Therefore, our aim for this study was to estimate the direct and indirect costs associated with muscle weakness in the Czech Republic. We applied a cost-of-illness approach using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). Six hundred and eighty-nine participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with gamma distribution was used, and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR =2.11), but did not have a statistically significant impact on indirect costs (OR =1.08) or on total cost (OR =1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR =2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs, and consequently place a burden on health care expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness among older people in the Czech Republic.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18024442
- 003
- CZ-PrNML
- 005
- 20201111105729.0
- 007
- ta
- 008
- 180709s2017 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/CIA.S150826 $2 doi
- 035 __
- $a (PubMed)29225462
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Steffl, Michal $u Department of Physiology and Biochemistry, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
- 245 14
- $a The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE) / $c M. Steffl, J. Sima, K. Shiells, I. Holmerova,
- 520 9_
- $a Muscle weakness and associated diseases are likely to place a considerable economic burden on government health care expenditure. Therefore, our aim for this study was to estimate the direct and indirect costs associated with muscle weakness in the Czech Republic. We applied a cost-of-illness approach using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). Six hundred and eighty-nine participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with gamma distribution was used, and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR =2.11), but did not have a statistically significant impact on indirect costs (OR =1.08) or on total cost (OR =1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR =2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs, and consequently place a burden on health care expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness among older people in the Czech Republic.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a osobní újma zaviněná nemocí $7 D017281
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a Evropa $7 D005060
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a výdaje na zdravotnictví $x statistika a číselné údaje $7 D005102
- 650 _2
- $a zdravotnické přehledy $7 D006306
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a svalová slabost $x ekonomika $x epidemiologie $7 D018908
- 650 _2
- $a odds ratio $7 D016017
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sima, Jan $u Department of Sport Management, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic.
- 700 1_
- $a Shiells, Kate $u Centre of Expertise in Longevity and Long-term Care, Faculty of Humanities, Charles University, Prague, Czech Republic.
- 700 1_
- $a Holmerova, Iva $u Centre of Expertise in Longevity and Long-term Care, Faculty of Humanities, Charles University, Prague, Czech Republic.
- 773 0_
- $w MED00173333 $t Clinical interventions in aging $x 1178-1998 $g Roč. 12, č. - (2017), s. 2003-2007
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29225462 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20201111105725 $b ABA008
- 999 __
- $a ok $b bmc $g 1316573 $s 1021363
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 12 $c - $d 2003-2007 $e 20171127 $i 1178-1998 $m Clinical interventions in aging $n Clin Interv Aging $x MED00173333
- GRA __
- $a NV15-32942A $p MZ0
- GRA __
- $a NV16-29182A $p MZ0
- LZP __
- $a Pubmed-20180709